Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
Journal
The Lancet Infectious Diseases
Journal Volume
21
Journal Issue
6
Pages
823-833
Date Issued
2021
Author(s)
Hsu Y.-C.
Chen C.-Y.
Chang I.-W.
Chang C.-Y.
Wu C.-Y.
Lee T.-Y.
Bair M.-J.
Chen J.-J.
Tseng C.-H.
Tai C.-M.
Huang Y.-T.
Ku W.-H.
Mo L.-R.
Lin J.-T.
SDGs
Publisher
Lancet Publishing Group
Type
journal article
